Literature DB >> 20083175

Characterization of plasma mediated molecular delivery to cells in vitro.

Richard J Connolly1, Gabriel A Lopez, Andrew M Hoff, Mark J Jaroszeski.   

Abstract

Ion-based strategies have recently emerged as a method to facilitate molecular delivery. These methods are attractive as they separate the applicator from the treatment site avoiding some issues encountered with other electrically driven methods. Current literature on plasma delivery has shown utility in vitro and in vivo for both drugs and genes. To advance this technology more information must become available on the mechanism responsible for delivery and the effects of ion exposure on eukaryotic cells. This in vitro investigation found that molecular delivery facilitated by a DC-based plasma follows a dose-response behavior, with optimum uptake of Sytox Green occurring in two cell lines after 600 s of exposure. In both cell lines exposure to the discharge caused no adverse effects in viability for exposure times up to 600 s. It was also found that membranes treated with ions remained permeabilized for several minutes following plasma treatment and that membrane resealing exhibited first order kinetics. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20083175     DOI: 10.1016/j.ijpharm.2010.01.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.

Authors:  Richard J Connolly; Taryn Chapman; Andrew M Hoff; Michele A Kutzler; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Quantitative evaluation of ultrasound-mediated cellular uptake of a fluorescent model drug.

Authors:  Matthieu Lepetit-Coiffé; Anna Yudina; Christel Poujol; Philippe Lourenco de Oliveira; Franck Couillaud; Chrit T W Moonen
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

3.  Direct Current Helium Plasma for In vivo Delivery of Plasmid DNA Encoding Erythropoietin to Murine Skin.

Authors:  Mark J Jaroszeski; Taryn Harvey-Chapman; Andrew Hoff; Reginald Atkins; Richard J Connolly
Journal:  Plasma Med       Date:  2017

4.  Optimization of a plasma facilitated DNA delivery method.

Authors:  Richard J Connolly; Andrew M Hoff; Richard Gilbert; Mark J Jaroszeski
Journal:  Bioelectrochemistry       Date:  2014-10-13       Impact factor: 5.373

5.  Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma.

Authors:  Richard J Connolly; Jose I Rey; Vance M Lambert; Garrett Wegerif; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Vaccine       Date:  2010-12-31       Impact factor: 3.641

6.  Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.

Authors:  Kevin Shah; Richard J Connolly; Taryn Chapman; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

7.  Delivery and expression of plasmid DNA into cells by a novel non-thermal plasma source.

Authors:  Eva Dolezalova; Muhammad A Malik; Loree Heller; Richard Heller
Journal:  Bioelectrochemistry       Date:  2021-04-05       Impact factor: 5.760

8.  Clarification of electrical current importance in plasma gene transfection by equivalent circuit analysis.

Authors:  Yugo Kido; Hideki Motomura; Yoshihisa Ikeda; Susumu Satoh; Masafumi Jinno
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

9.  Cold Atmospheric Plasma Promotes Killing of Staphylococcus aureus by Macrophages.

Authors:  Constance Duchesne; Nadira Frescaline; Océane Blaise; Jean-Jacques Lataillade; Sébastien Banzet; Olivier Dussurget; Antoine Rousseau
Journal:  mSphere       Date:  2021-06-16       Impact factor: 4.389

10.  Plasma-activated air mediates plasmid DNA delivery in vivo.

Authors:  Chelsea M Edelblute; Loree C Heller; Muhammad A Malik; Anna Bulysheva; Richard Heller
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-13       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.